Self-management measurement instruments specific to individuals with cardiovascular diseases: a systematic review

Jose Alexandre Barbosa de Almeida1,2, Karolinne Souza Monteiro1,2, Thayla Amorim Santino3

  • 1Faculty of Health Sciences of Trairi, Federal University of Rio Grande do Norte, Santa Cruz, Brazil.

BMJ Open
|December 9, 2025
PubMed

Insights

This systematic review evaluates health measurement instruments for cardiovascular disease self-management. It assesses the quality of tools to monitor patient health and improve outcomes.

Area of Science:

  • Health Sciences
  • Clinical Research
  • Patient Self-Management

Background:

  • Cardiovascular diseases (CVDs) are a leading global cause of mortality.
  • Effective self-management strategies are vital for preventing CVD complications and improving patient outcomes.
  • Validated instruments are essential for accurately measuring self-management behaviors.

Purpose of the Study:

  • To systematically review and assess the quality of patient-reported instruments for measuring self-management in adults with CVDs.
  • To apply the Consensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology for robust evaluation.
  • To identify reliable tools for monitoring CVD self-management and informing clinical practice.

Main Methods:

  • A systematic review following COSMIN guidelines and Preferred Reporting Items for Systematic Review and Meta-analysis Protocol.
  • Comprehensive literature searches across seven major databases and manual searches of relevant websites.
  • Inclusion of studies on the development and validation of patient-reported self-management instruments for CVDs, with no date or language restrictions.

Main Results:

  • The review will assess the psychometric properties and content of selected instruments.
  • Data extraction and quality assessment will adhere to COSMIN standards.
  • Evidence quality will be determined using the Modified Grading of Recommendations, Assessment, Development and Evaluation approach.

Conclusions:

  • This review will provide a critical evaluation of existing CVD self-management instruments.
  • Findings will guide the selection of high-quality measurement tools for research and clinical practice.
  • The results aim to enhance the reliability and validity of self-management assessments in cardiovascular care.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
738
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
299
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
234
Stress Prevention and Stress Management Techniques I01:26

Stress Prevention and Stress Management Techniques I

Stress prevention and management are crucial for maintaining well-being and building resilience. Techniques to manage stress include cultivating qualities like conscientiousness, a sense of personal control, and self-efficacy. Each of these traits significantly reduces stress and promotes healthier lifestyle choices and outcomes.
Conscientiousness
Conscientious individuals tend to be organized, responsible, and disciplined. They prioritize completing tasks and following structured routines,...
259
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374